Discovery doubles down on healthtech with US acquisition

Discovery paid US$27m (about R435m) upfront for Icario, with a further US$32.5m potentially payable depending on the company’s performance. That could take the total value of the transaction to US$59.5m (about R958m).

While the size of the deal is significant, its strategic value lies in the technology and healthcare capabilities Discovery is adding to its international platform.

From insurance to digital health

Icario specialises in technology that helps health plans engage their members and encourage healthier behaviours.

Its platform reaches roughly 11 million people, primarily through US government-sponsored healthcare programmes such as Medicaid and Medicare Advantage.

That gives Discovery access to a substantial healthcare technology and member-engagement ecosystem at a time when health insurers globally are increasingly looking to digital platforms, analytics and AI to improve patient outcomes while controlling costs.

For Discovery, Icario adds capabilities in member activation, digital engagement and health-plan technology — areas that complement the behavioural-health model underpinning Vitality.

The acquisition also gives Discovery an opportunity to introduce additional health and wellness services to Icario's existing customer base.

AI is becoming the HealthTech engine

The Icario acquisition is part of a much broader technology strategy.

Discovery has been investing heavily in building AI and data capabilities across healthcare, insurance and customer engagement. Its US expansion has included the acquisition of workplace wellness businesses WellSpark and Ramp Health, alongside a partnership with HealthEquity.

The US business increased revenue by 22% in the latest financial year and expanded to 10 health plans, with approximately 3.6 million covered members.

Discovery is now incorporating AI into its engagement offering, signalling a shift from simply providing wellness programmes towards developing technology-enabled healthcare interventions.

The opportunity is to use data to understand member behaviour, identify health risks and deliver more personalised interventions through digital channels.

Building a global HealthTech platform

The strategy extends beyond the US.

Discovery owns 25% of Amplify Health, alongside AIA, which has been developing technology and analytics solutions for insurers and healthcare organisations across Asia.

Amplify Health's partnership with Indian insurer Star Health, for example, focuses on applying AI to claims intelligence and healthcare analytics.

Taken together, these investments point to an increasingly technology-led healthcare strategy: collecting and analysing health data, using AI to generate insights, and then turning those insights into digital interventions that can influence healthcare behaviour and outcomes.

This potentially moves Discovery further up the healthcare value chain — from paying for healthcare to helping manage and influence how healthcare is delivered and consumed.

A costly technology transition

The strategy is not without a significant investment cost.

Discovery's Vitality AI segment recorded a R299m loss in FY2026, with spending increasing across customer engagement, healthcare, underwriting and operational processes.

The figure also includes other central Vitality costs, but it illustrates the scale of investment required to build technology capabilities at a global level.

The Icario acquisition adds another component to that strategy, particularly in the US market where government-sponsored healthcare represents a large and growing opportunity for technology-enabled health management.

HealthTech becomes a core growth opportunity

Discovery's latest acquisition suggests that HealthTech is becoming increasingly central to the group's international growth strategy.

Rather than treating technology as an add-on to insurance, Discovery is building a model around AI, healthcare analytics, digital engagement, behavioural science and health-plan technology.

The long-term opportunity is to create platforms that can help insurers and healthcare organisations better understand their members, intervene earlier and personalise healthcare at scale.

For Discovery, the US is emerging as an important testing ground for that model — and Icario gives the group another significant piece of the HealthTech infrastructure needed to pursue it.